FDA Approved Products

Application #	Type	Sponsor	Notes	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
761192	BLA	MEDIWOUND, LTD		001	NEXOBRID	GEL;TOPICAL	8.8%	ANACAULASE-BCDB	2022-12-28	Prescription	No